IBDEI0SP ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14143,1,4,0)
 ;;=4^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,14143,1,5,0)
 ;;=5^054.11
 ;;^UTILITY(U,$J,358.3,14143,2)
 ;;=^57012
 ;;^UTILITY(U,$J,358.3,14144,0)
 ;;=054.13^^85^877^32
 ;;^UTILITY(U,$J,358.3,14144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14144,1,4,0)
 ;;=4^Herpectic Infect of Penis
 ;;^UTILITY(U,$J,358.3,14144,1,5,0)
 ;;=5^054.13
 ;;^UTILITY(U,$J,358.3,14144,2)
 ;;=^266560
 ;;^UTILITY(U,$J,358.3,14145,0)
 ;;=070.1^^85^877^24
 ;;^UTILITY(U,$J,358.3,14145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14145,1,4,0)
 ;;=4^Hepatitis A
 ;;^UTILITY(U,$J,358.3,14145,1,5,0)
 ;;=5^070.1
 ;;^UTILITY(U,$J,358.3,14145,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,14146,0)
 ;;=070.30^^85^877^25
 ;;^UTILITY(U,$J,358.3,14146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14146,1,4,0)
 ;;=4^Hepatitis B,Acute
 ;;^UTILITY(U,$J,358.3,14146,1,5,0)
 ;;=5^070.30
 ;;^UTILITY(U,$J,358.3,14146,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,14147,0)
 ;;=070.32^^85^877^26
 ;;^UTILITY(U,$J,358.3,14147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14147,1,4,0)
 ;;=4^Hepatitis B,Chronic
 ;;^UTILITY(U,$J,358.3,14147,1,5,0)
 ;;=5^070.32
 ;;^UTILITY(U,$J,358.3,14147,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,14148,0)
 ;;=070.51^^85^877^27
 ;;^UTILITY(U,$J,358.3,14148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14148,1,4,0)
 ;;=4^Hepatitis C,Acute
 ;;^UTILITY(U,$J,358.3,14148,1,5,0)
 ;;=5^070.51
 ;;^UTILITY(U,$J,358.3,14148,2)
 ;;=^331778
 ;;^UTILITY(U,$J,358.3,14149,0)
 ;;=070.54^^85^877^28
 ;;^UTILITY(U,$J,358.3,14149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14149,1,4,0)
 ;;=4^Hepatitis C,Chronic
 ;;^UTILITY(U,$J,358.3,14149,1,5,0)
 ;;=5^070.54
 ;;^UTILITY(U,$J,358.3,14149,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,14150,0)
 ;;=070.59^^85^877^31
 ;;^UTILITY(U,$J,358.3,14150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14150,1,4,0)
 ;;=4^Hepatitis,Oth Viral
 ;;^UTILITY(U,$J,358.3,14150,1,5,0)
 ;;=5^070.59
 ;;^UTILITY(U,$J,358.3,14150,2)
 ;;=^266631
 ;;^UTILITY(U,$J,358.3,14151,0)
 ;;=079.99^^85^877^83
 ;;^UTILITY(U,$J,358.3,14151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14151,1,4,0)
 ;;=4^Viral Syndrome
 ;;^UTILITY(U,$J,358.3,14151,1,5,0)
 ;;=5^079.99
 ;;^UTILITY(U,$J,358.3,14151,2)
 ;;=^295798
 ;;^UTILITY(U,$J,358.3,14152,0)
 ;;=088.81^^85^877^41
 ;;^UTILITY(U,$J,358.3,14152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14152,1,4,0)
 ;;=4^Lyme Disease
 ;;^UTILITY(U,$J,358.3,14152,1,5,0)
 ;;=5^088.81
 ;;^UTILITY(U,$J,358.3,14152,2)
 ;;=^72315
 ;;^UTILITY(U,$J,358.3,14153,0)
 ;;=091.0^^85^877^71
 ;;^UTILITY(U,$J,358.3,14153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14153,1,4,0)
 ;;=4^Syphilis,Primary,Genital
 ;;^UTILITY(U,$J,358.3,14153,1,5,0)
 ;;=5^091.0
 ;;^UTILITY(U,$J,358.3,14153,2)
 ;;=^50581
 ;;^UTILITY(U,$J,358.3,14154,0)
 ;;=094.9^^85^877^70
 ;;^UTILITY(U,$J,358.3,14154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14154,1,4,0)
 ;;=4^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,14154,1,5,0)
 ;;=5^094.9
 ;;^UTILITY(U,$J,358.3,14154,2)
 ;;=^83026
 ;;^UTILITY(U,$J,358.3,14155,0)
 ;;=097.0^^85^877^69
 ;;^UTILITY(U,$J,358.3,14155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14155,1,4,0)
 ;;=4^Syphilis,Latent
 ;;^UTILITY(U,$J,358.3,14155,1,5,0)
 ;;=5^097.0
 ;;^UTILITY(U,$J,358.3,14155,2)
 ;;=^266781
 ;;^UTILITY(U,$J,358.3,14156,0)
 ;;=097.9^^85^877^68
 ;;^UTILITY(U,$J,358.3,14156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14156,1,4,0)
 ;;=4^Syphilis NOS
 ;;^UTILITY(U,$J,358.3,14156,1,5,0)
 ;;=5^097.9
 ;;^UTILITY(U,$J,358.3,14156,2)
 ;;=^116808
 ;;^UTILITY(U,$J,358.3,14157,0)
 ;;=098.0^^85^877^78
